SCHEMBL6979848

SCHEMBL6979848

C=CCC1CCCCC(=O)N1C(=O)OC(C)(C)C

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 2/20 0.37
PARP1 P09874 1/20 0.35
CHRM2 P08172 1/20 0.35
CHRM1 P11229 1/20 0.35
CHRM3 P20309 1/20 0.35
MEN1 O00255 1/20 0.34
ALDH1A1 P00352 1/20 0.34
KMT2A Q03164 1/20 0.34
ELANE P08246 2/20 0.34
DDB1 Q16531 2/20 0.33
CRBN Q96SW2 2/20 0.33
EPHX1 P07099 2/20 0.33
PDE8B O95263 1/20 0.33
HPGD P15428 1/20 0.32
KDM1A O60341 1/20 0.32
CHRNB2 P17787 1/20 0.32
CHRNB4 P30926 1/20 0.32
CHRNA3 P32297 1/20 0.32
CHRNA7 P36544 1/20 0.32
CHRNA4 P43681 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6972167 0.88 ATM (0.38) ATMPARP1CHRM2CHRM1CHRM3
SCHEMBL6974955 0.83 CHRM2 (0.37) ATMPARP1CHRM2CHRM1CHRM3
SCHEMBL6979936 0.82 ATM (0.34) ATMPARP1CHRM2CHRM1CHRM3
SCHEMBL6979934 0.82 ATM (0.34) ATMPARP1CHRM2CHRM1CHRM3
SCHEMBL8592642 0.82 CHRM2 (0.35) CHRM2CHRM1CHRM3ELANEDDB1
SCHEMBL6969595 0.81 DDB1 (0.38) ATMPARP1CHRM2CHRM1CHRM3
SCHEMBL6976407 0.79 USP2 (0.32) ATM
SCHEMBL29997809 0.77 KLK7 (0.48) PARP1KMT2AGPR119
SCHEMBL6969013 0.77 KLK7 (0.48) PARP1KMT2AGPR119
SCHEMBL8594075 0.76 CHRM2 (0.34) CHRM2CHRM1CHRM3ELANEDDB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0821674-B1 CYCLIC AMIDINO AGENTS USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS SEARLE & CO (US) 2003-08-06 EP disclosed
US-6043261-A TREATMENT OF INFLAMMATORY CONDITIONS AFFECTING THE JOINTS, FOR EXAMPLE ARTHRITIS, INFLAMMATORY BOWEL DISEASE, CARDIOVASCULAR ISCHEMIA, DIABETES, HYPERALGESIA, CEREBRAL ISCHEMIA, THROMBOTIC STROKE, GLOBAL ISCHEMIA, NERVOUS SYSTEM DISORDERS G. D. SEARLE & CO. (US) 2000-03-28 US disclosed
US-6011028-A Cyclic amidino agents useful as nitric oxide synthase inhibitors G.D. SEARLE & CO. (US) 2000-01-04 US disclosed
EP-0901497-A1 YTTRIUM CONTAINING METAL COMPLEXES AND OLEFIN POLYMERIZATION PROCESS THE DOW CHEMICAL COMPANY (US) 1999-03-17 EP disclosed
US-5883251-A ENZYME INHIBITORS G. D. SEARLE & CO. (US) 1999-03-16 US disclosed
EP-0821674-A1 CYCLIC AMIDINO AGENTS USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS G.D. SEARLE & CO. (US) 1998-02-04 EP disclosed
WO-1997043294-A1 YTTRIUM CONTAINING METAL COMPLEXES AND OLEFIN POLYMERIZATION PROCESS THE DOW CHEMICAL COMPANY (US) 1997-11-20 WO disclosed
WO-1996033175-A1 CYCLIC AMIDINO AGENTS USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS G.D. SEARLE & CO. (US) 1996-10-24 WO disclosed